---
figid: PMC11223907__APS2024-4862706.001
pmcid: PMC11223907
image_filename: PMC11223907__APS2024-4862706.001.jpg
figure_link: /pmc/articles/PMC11223907/figure/F1/
number: Figure 1
figure_title: Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its
  Effect on Bioactivation and Pharmacokinetics
caption: Cyclophosphamide mechanism of action on DNA showing the inter- and intrastrand
  crosslinks that cause DNA damage and trigger apoptosis in cancer cells (a) and its
  metabolic pathway showing its bioactivation from a prodrug to an active agent and
  its terminal cytotoxic metabolites (b)
article_title: Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and
  Its Effect on Bioactivation and Pharmacokinetics
citation: Ibrahim El-Serafi, et al. Adv Pharmacol Pharm Sci. 2024;2024(NA).
year: '2024'
pub_date: 2024--
epub_date: 2024-6-27
doi: 10.1155/2024/4862706
journal_title: Advances in Pharmacological and Pharmaceutical Sciences
journa_nlm_ta: Adv Pharmacol Pharm Sci
publisher_name: Wiley
keywords: []
---
